163068-20-0

Basic information

• Product Name: N-(4-benzyloxyphenyl)-N-(2,2-diethoxyethyl)-N'-[2-(ethoxycarbonyl)ethyl]-urea
• Synonyms: N-(4-benzyloxyphenyl)-N-(2,2-diethoxyethyl)-N'-[2-(ethoxycarbonyl)ethyl]-urea
• CAS NO: 163068-20-0
• Molecular Weight: 458.555
• Mol File: 163068-20-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(4-benzyloxyphenyl)-N-(2,2-diethoxyethyl)-N'-[2-(ethoxycarbonyl)ethyl]-urea(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-benzyloxyphenyl)-N-(2,2-diethoxyethyl)-N'-[2-(ethoxycarbonyl)ethyl]-urea(163068-20-0)
• EPA Substance Registry System: N-(4-benzyloxyphenyl)-N-(2,2-diethoxyethyl)-N'-[2-(ethoxycarbonyl)ethyl]-urea(163068-20-0)

Safety Data

• Hazardous Substances Data: 163068-20-0(Hazardous Substances Data)

Upstream product

• 163068-19-7 N-(2,2-diethoxyethyl)-4-benzyloxy-aniline 
• 5100-34-5 ethyl 3-isocyanatopropanoate 

Downstream Products

• 163068-21-1 1-(4-benzyloxyphenyl)-3-[2-(ethoxycarbonyl)ethyl]-3H-imidazol-2-one 

Relevant articles and documents

Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them

The invention relates to cyclic derivatives of general formula STR1 wherein Ra, Rb, X and Y are as defined in claim 1, the tautomers, the stereoisomers including the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable pharmacological properties, preferably aggregation-inhibiting effects, pharmaceutical compositions containing the compounds and processes for preparing them.